- Home
- BAX vs ICLR Comparison
BAX vs ICLR Comparison
Compare BAX & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BAX | ICLR |
|---|---|---|
| Founded | 1931 | 1990 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.4B | 14.3B |
| IPO Year | N/A | 1998 |
Fundamental Metrics
Financial Performance| Metric | BAX | ICLR |
|---|---|---|
| Price | $18.60 | $185.83 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 10 | 14 |
| Target Price | $25.67 | ★ $201.23 |
| AVG Volume (30 Days) | ★ 8.3M | 1.0M |
| Earning Date | 10-30-2025 | 10-22-2025 |
| Dividend Yield | ★ 0.22% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 7.47 |
| Revenue | ★ $11,023,000,000.00 | $8,102,602,000.00 |
| Revenue This Year | $5.20 | N/A |
| Revenue Next Year | $2.02 | $0.76 |
| P/E Ratio | ★ N/A | $24.87 |
| Revenue Growth | ★ 3.90 | N/A |
| 52 Week Low | $17.40 | $125.10 |
| 52 Week High | $37.74 | $228.29 |
Technical Indicators
Market Signals| Indicator | BAX | ICLR |
|---|---|---|
| Relative Strength Index (RSI) | 43.20 | 62.18 |
| Support Level | $18.33 | $174.13 |
| Resistance Level | $19.17 | $191.15 |
| Average True Range (ATR) | 0.54 | 8.46 |
| MACD | 0.21 | 2.87 |
| Stochastic Oscillator | 63.23 | 85.77 |
Price Performance
Historical ComparisonAbout BAX Baxter International Inc.
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.
About ICLR ICON plc
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.